Page last updated: 2024-11-12
ramoplanin a2
Description
ramoplanin A2: macrocyclic depsipeptide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (11)
| Synonym |
|---|
| 81988-88-7 |
| ramoplanin a2 |
| C12008 , |
| ramoplanin a2 (main component) |
| ramoplanin a 1 (peptide moiety), 1-(n(sup 2)-(7-methyl-1-oxo-2,4-octadienyl)-l-asparagine)-11-(l-2-(4-((2-o-alpha-d-mannopyranosyl-alpha-d-mannopyranosyl)oxy)phenyl)glycine)-,(z,z)- |
| unii-i9bj0br28x |
| i9bj0br28x , |
| ramoplanin a 1, 1-(n2-((2z,4e)-7-methyl-1-oxo-2,4-octadien-1-yl)-l-asparagine)- |
| ramoplanin a2 [mi] |
| antibiotic a-16686a2 |
| CHEBI:29670 |
Drug Classes (1)
| Class | Description |
|---|
| polyol | A compound that contains two or more hydroxy groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |